Evidence map›Paper›PMID 33419327›Full record

ArticleBiomedicines2020

Biocompatibility and Immune Response of a Newly Developed Volume-Stable Magnesium-Based Barrier Membrane in Combination with a PVD Coating for Guided Bone Regeneration (GBR).

Larissa Steigmann, Ole Jung, Wolfgang Kieferle, Sanja Stojanovic, Annica Proehl, Oliver Görke, Steffen Emmert, Stevo Najman, Mike Barbeck, Daniel Rothamel

Abstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Materials advances in GTR membrane: A comprehensive review.Journal of Taibah University Medical Sciences · 2026
    Review
  3. Review
  4. Research status and prospects of biodegradable magnesium-based metal guided bone regeneration membranes.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Advances in Barrier Membranes for Guided Bone Regeneration Techniques.Frontiers in bioengineering and biotechnology · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. In vivo (Athens, Greece)
    Article
  18. Review
  19. Republication:In vivo (Athens, Greece)
    Article
  20. In vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Larissa SteigmannDepartment of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.
Ole JungClinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, D-18057 Rostock, Germany.ORCID 0000-0001-8005-2916
Wolfgang KieferleTS TriboSystems GmbH, D-88250 Weingarten, Germany.
Sanja StojanovicDepartment of Biology and Human Genetics, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.
Annica ProehlResearch Department, BerlinAnalytix GmbH, D-12109 Berlin, Germany.ORCID 0000-0001-7251-7621
Oliver GörkeDepartment of Ceramic Materials, Chair of Advanced Ceramic Materials, Institute for Materials Science and Technologies, Technical University Berlin, D-10623 Berlin, Germany.
Steffen EmmertClinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, D-18057 Rostock, Germany.
Stevo NajmanDepartment of Biology and Human Genetics, Faculty of Medicine, University of Niš, 18000 Niš, Serbia.ORCID 0000-0002-2411-9802
Mike BarbeckResearch Department, BerlinAnalytix GmbH, D-12109 Berlin, Germany.ORCID 0000-0002-3001-1347
Daniel RothamelDepartment of Oral and Maxillofacial Plastic Surgery, Evangelic Johanniter Hospital Bethesda Mönchengladbach, D-41061 Mönchengladbach, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, there are no bioresorbable alternatives to non-resorbable and volume-stable membranes in the field of dentistry for guided bone or tissue regeneration (GBR/GTR). Even magnesium (Mg) has been shown to constitute a favorable biomaterial for the development of stabilizing structures. However, it has been described that it is necessary to prevent premature degradation to ensure both the functionality and the biocompatibility of such Mg implants. Different coating strategies have already been developed, but most of them did not provide the desired functionality. The present study analyses a new approach based on ion implantation (II) with PVD coating for the passivation of a newly developed Mg membrane for GBR/GTR procedures. To demonstrate comprehensive biocompatibility and successful passivation of the Mg membranes, untreated Mg (MG) and coated Mg (MG-Co) were investigated in vitro and in vivo. Thereby a collagen membrane with an already shown biocompatibility was used as control material. All investigations were performed according to EN ISO 10993 regulations. The in vitro results showed that both the untreated and PVD-coated membranes were not cytocompatible. However, both membrane types fulfilled the requirements for in vivo biocompatibility. Interestingly, the PVD coating did not have an influence on the gas cavity formation compared to the uncoated membrane, but it induced lower numbers of anti-inflammatory macrophages in comparison to the pure Mg membrane and the collagen membrane. In contrast, the pure Mg membrane provoked an immune response that was fully comparable to the collagen membrane. Altogether, this study shows that pure magnesium membranes represent a promising alternative compared to the nonresorbable volume-stable materials for GBR/GTR therapy.

Indexed as

barrier membranebiocompatibilitycytocompatibilitydentistryguided bone regenerationmacrophagemagnesium implant

Identifiers

PMID33419327
PMCPMC7767206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.